2028 年北美表柔比星市场预测——COVID-19 影响和区域分析——按剂量（10 毫克/瓶、50 毫克/瓶、100 毫克/瓶和 200 毫克/瓶）、应用（乳腺癌、肝癌、膀胱癌等）和分销渠道（医院药房、零售药房和在线药房）划分
No. of Pages: 95 | Report Code: BMIRE00027259 | Category: Life Sciences
No. of Pages: 95 | Report Code: BMIRE00027259 | Category: Life Sciences
北美表阿霉素市场预计将从2022年的95,445.28万美元增长到2028年的1,18,596.58万美元；预计 2022 年至 2028 年复合年增长率为 3.7%。
上升FDA 批准抗癌药物带来丰厚的市场机会
2022 年 6 月 22 日，美国食品和药物管理局 (FDA) 加速批准达拉非尼的使用，该药物由诺华公司以商品名 Tafinlar 与诺华公司以商品名 Mekinist 销售的曲美替尼 (Trametinib) 联合销售，用于治疗患有 BRAF V600E 突变的实体转移瘤患者，特别是六岁以上的儿科患者。 2017年12月1日，FDA批准Ogivri（曲妥珠单抗-dkst）作为赫赛汀（曲妥珠单抗）的生物仿制药，用于治疗乳腺癌或转移性胃癌（胃或胃食管交界腺癌），其肿瘤具有HER2基因同工型（HER2+）。 2022 年 5 月 27 日，FDA 批准了百时美施贵宝公司以 Opdivo 品牌销售的 Nvolumab 与氟嘧啶类和铂类化疗药物联用，以及以 Yervoy 品牌销售的 nivolumab 与伊匹单抗联用百时美施贵宝公司生产的用于晚期或转移性食管鳞状细胞癌（ESCC）患者的一线治疗。 2022 年 3 月 11 日，FDA 批准阿斯利康制药公司以 Lynparza 品牌销售的奥拉帕尼用于治疗乳腺癌患者。此外，2021 年 5 月，FDA 加速批准将免疫治疗药物 pembrolizumab (Keytruda) 与食管或胃 HER2+ 肿瘤患者的标准治疗相结合。因此，FDA 批准数量的增加为表阿霉素市场的增长提供了利润丰厚的机会。
市场概览
北美表阿霉素市场分为美国、加拿大和墨西哥。 2021 年，美国占据最大的市场份额。乳腺癌患病率不断上升，研究和研究不断增加，开发活动以及对治疗癌症的先进治疗解决方案的需求不断增加是推动市场增长的突出因素。美国乳腺癌患病率的增加可能会增加对表阿霉素的需求。根据美国疾病控制与预防中心 (CDC) 的数据，在美国，每年诊断出约 2,64,000 例女性乳腺癌病例，约 2,400 例男性乳腺癌病例。此外，表柔比星还用于治疗膀胱癌。美国癌症协会估计，到2022年底，将有81,180例新发膀胱癌病例。此外，美国医药市场是北美最大、最商业化的市场；它占据全球医药市场45%以上的份额。大多数全球领先的药品制造公司都位于美国，活跃于医疗设备/诊断和消费品的制造领域。因此，预计该国癌症患病率的增加将在预测期内推动美国表阿霉素市场的增长。
北美表柔比星市场细分
北美表柔比星市场根据剂量、应用、分销渠道和国家进行细分。根据剂量，北美表阿霉素市场分为10毫克/瓶、50毫克/瓶、100毫克/瓶和200毫克/瓶。 2022年，50毫克/瓶细分市场占据最大的市场份额。根据应用，北美表阿霉素市场分为乳腺癌、肝癌、膀胱癌等。 2022年，乳腺癌细分市场占据最大的市场份额。根据分销渠道，北美表阿霉素市场分为医院药房、零售药房和在线药房。 2022年，医院药房领域占据最大的市场份额。按国家划分，北美表柔比星市场分为美国、加拿大和墨西哥。此外，美国在 2022 年占据主导地位。eva Pharmaceuticals、Fresenius Kabi AG、Hikma Pharmaceuticals PLC、Mylan NV、辉瑞公司、Salius Pharma Pvt Ltd 和 Teva Pharmaceutical Industries Ltd. 是领先公司经营北美表柔比星市场。
Strategic insights for North America Epirubicin involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 95,445.28 thousand |
| Market Size by 2028 | US$ 1,18,596.58 thousand |
| Global CAGR (2022 - 2028) | 3.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 剂量
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Epirubicin refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Epirubicin Market is valued at US$ 95,445.28 thousand in 2022, it is projected to reach US$ 1,18,596.58 thousand by 2028.
As per our report North America Epirubicin Market, the market size is valued at US$ 95,445.28 thousand in 2022, projecting it to reach US$ 1,18,596.58 thousand by 2028. This translates to a CAGR of approximately 3.7% during the forecast period.
The North America Epirubicin Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Epirubicin Market report:
The North America Epirubicin Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Epirubicin Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Epirubicin Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Epirubicin Market
